
RCM Technologies (RCMT) Stock Forecast & Price Target
RCM Technologies (RCMT) Analyst Ratings
Bulls say
RCM Technologies is supported by a resilient mix of high-growth Specialty Health Care and improving Engineering and Life Sciences operations, with 2Q26 revenue rising 20.2% year over year to $93.8M and adjusted EPS increasing to $0.82 from $0.69. Specialty Health Care delivered $44.7M of revenue with 29.4% gross margin, while Engineering grew 49.0% on strong Energy Services and EPC demand tied to grid modernization and data center buildout, despite margin pressure from subcontractor mix. Its asset-light model also produced $13.5M of operating cash flow in 2Q26 and over 54% Y/Y growth in 1H26, reinforcing the outlook for strong cash generation, backlog conversion, and shareholder returns.
Bears say
RCM Technologies is vulnerable to multiple fundamental risks that can pressure results, including acquisition integration challenges, limited stock liquidity, and dependence on favorable financing for bolt-on M&A. Its revenue base is concentrated in North America and exposed to cyclical end markets such as engineering and construction, while labor shortages, regulatory changes, and competitive pressure from larger firms could weaken margins and slow growth. Client concentration is also notable, with the New York City Board of Education representing 10.6% of revenues in 2020 and the top five customers 33.4%, amplifying downside if demand or execution deteriorates.
This aggregate rating is based on analysts' research of RCM Technologies and is not a guaranteed prediction by Public.com or investment advice.
RCM Technologies (RCMT) Analyst Forecast & Price Prediction
Start investing in RCM Technologies (RCMT)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About RCM Technologies (RCMT) Forecast
RCM Technologies (RCMT) Analyst Forecast & Price Prediction
Start investing in RCM Technologies (RCMT)
Order type
Buy in
Order amount
Est. shares
0 shares